Schwabe Stefan K.F.
Executive Vice President & CMO at SUPERNUS PHARMACEUTICALS, INC.
- Sold, on record
- $10.1M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Dec 21, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- SUPERNUS PHARMACEUTICALS, INC.Executive Vice President & CMO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.UnusualJun 11, 2015 2015
Sold 3,631 shares at $16.40 ($60k)
Schwabe Stefan K.F., Executive Vice President R&D
Sold 42.8% of holdings ($139k position)4,845 shares leftFirst sale on recordFiling
- 2 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.UnusualJun 12, 2015 +1 day
Sold 2,051 shares at $18.27 ($37k)
Schwabe Stefan K.F., Executive Vice President R&D
Sold 42.3% of holdings ($89k position)2,794 shares leftFiling
- 3 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.UnusualJul 13, 2015 +31 days
Sold 1,950 shares at $19.23 ($37k)
Schwabe Stefan K.F., Executive Vice President R&D
Sold 69.8% of holdings ($54k position)844 shares leftFiling
- 4 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.UnusualJul 28, 2015 +15 days
Sold 2,350 shares at $21.20 ($50k)
Schwabe Stefan K.F., Executive Vice President R&D
Sold 100% of holdings ($50k position)0 shares left1.1x usual sizeFiling
- 5 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.UnusualSep 7, 2017 +772 days
Sold 95,000 shares at $46.59 ($4.4M)
Schwabe Stefan K.F., Executive Vice President R&D
Sold 98.1% of holdings ($4.5M position)1,855 shares leftFirst sale on recordFiling
- 6 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.UnusualJun 18, 2018 +284 days
Sold 60,000 shares at $54.39 ($3.3M)
Schwabe Stefan K.F., Executive VP R&D, CMO
Sold 96.8% of holdings ($3.4M position)1,967 shares leftFiling
- 7 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.UnusualDec 14, 2020 +910 days
Sold 53,653 shares at $21.87 ($1.2M)
Schwabe Stefan K.F., Executive Vice President & CMO
Sold 95.1% of holdings ($1.2M position)2,772 shares leftFirst sale on recordFiling
- 8 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.UnusualDec 21, 2020 +7 days
Sold 46,347 shares at $22.10 ($1M)
Schwabe Stefan K.F., Executive Vice President & CMO
Sold 94.4% of holdings ($1.1M position)2,772 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2020 | Dec 22, 2020 | SUPERNUS PHARMACEUTICALS, INC. | Executive Vice President & CMO | Form 4 sale | 46,347 | $1M | 94.4% | Unusual | SEC |
| Dec 14, 2020 | Dec 15, 2020 | SUPERNUS PHARMACEUTICALS, INC. | Executive Vice President & CMO | Form 4 sale | 53,653 | $1.2M | 95.1% | Unusual | SEC |
| Jun 18, 2018 | Jun 19, 2018 | SUPERNUS PHARMACEUTICALS, INC. | Executive VP R&D, CMO | Form 4 sale | 60,000 | $3.3M | 96.8% | Unusual | SEC |
| Sep 7, 2017 | Sep 11, 2017 | SUPERNUS PHARMACEUTICALS, INC. | Executive Vice President R&D | Form 4 sale | 95,000 | $4.4M | 98.1% | Unusual | SEC |
| Jul 28, 2015 | Jul 29, 2015 | SUPERNUS PHARMACEUTICALS, INC. | Executive Vice President R&D | Form 4 sale | 2,350 | $50k | 100.0% | Unusual | SEC |
| Jul 13, 2015 | Jul 14, 2015 | SUPERNUS PHARMACEUTICALS, INC. | Executive Vice President R&D | Form 4 sale | 1,950 | $37k | 69.8% | Unusual | SEC |
| Jun 12, 2015 | Jun 15, 2015 | SUPERNUS PHARMACEUTICALS, INC. | Executive Vice President R&D | Form 4 sale | 2,051 | $37k | 42.3% | Unusual | SEC |
| Jun 11, 2015 | Jun 12, 2015 | SUPERNUS PHARMACEUTICALS, INC. | Executive Vice President R&D | Form 4 sale | 3,631 | $60k | 42.8% | Unusual | SEC |